HomeNewsBusinessEconomyEXPLAINED | The credit guarantee schemes announced by FM to ease Covid-induced financial pain

EXPLAINED | The credit guarantee schemes announced by FM to ease Covid-induced financial pain

Finance Minister Nirmala Sitharman on 28 June listed out initiatives costing a total of Rs. 6.29 lakh crore. The overwhelming majority of this however, will be spread across the series of credit guarantee schemes spread across sectors. We take a look at the details.

June 28, 2021 / 19:55 IST
Story continues below Advertisement
Finance Minister Nirmala Sitharaman (File image: Reuters)
Finance Minister Nirmala Sitharaman (File image: Reuters)

After the domestic industry increasingly raised demand for another major economic package for the Covid-19 got louder over the past few months, the government has come out with a series of announcements.

Effectively tied together another round of fiscal stimulus into the economy, the announcements come after macro indicators showed demand to have slipped dangerously low in the economy.

Story continues below Advertisement

The credit guarantee schemes are intended to address this by providing liquidity to key segments of the populations, including small businesses, struggling poor and the worst hit sectors.

Loan Guarantee Scheme for COVID Affected Sectors

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show